BusinessUPDATE: Puration Announces Plans To Produce THC Infused Beverage For Legal Canadian Recreational Marijuana MarketBy Nasdaq OMXMay 1, 2018, 2:44 PM UTC
BusinessTherapeutic Solutions International Launches Multi-Protocol Cancer Immunotherapy Clinical Trial with Pan Am Cancer TreatmentBy Nasdaq OMXMay 1, 2018, 1:02 PM UTC
BusinessGeoVax and Vaxeal to Collaborate on Cancer Immunotherapy ProgramBy Nasdaq OMXJan 3, 2018, 2:00 PM UTC
BusinessBioLabs@NYULangone Coworking Space for Life Sciences is Open for Business in Hudson Square with Four High-Potential Startups Already in ResidenceBy Nasdaq OMXDec 12, 2017, 1:02 PM UTC
BusinessFluidigm Introduces Immuno-Oncology Gene Expression Assay for Translational and Clinical ResearchBy Nasdaq OMXJul 18, 2017, 1:01 PM UTC
BusinessGlobal Cancer Immunotherapy Market & Clinical Trials Outlook 2022: Download Report, Market Opportunity at USD 100 Billion, Clinical Trial Insight by Drug ClassBy Nasdaq OMXJun 26, 2017, 8:13 AM UTC
BusinessBiothera Announces Three Presentations at Upcoming American Association for Cancer Research (AACR) Annual MeetingBy Nasdaq OMXMar 27, 2017, 3:00 PM UTC
BusinessBiothera Pharmaceuticals’ Phase 2 Study of Imprime PGG Combination Therapy in Non-Small Cell Lung Cancer Patients Published in Investigational New DrugsBy Nasdaq OMXMar 24, 2017, 2:00 PM UTC
